Autoimmune Disease Treatment Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Autoimmune Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autoimmune Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autoimmune Disease Treatment Overall Market Size
2.1 Global Autoimmune Disease Treatment Market Size: 2021 VS 2027
2.2 Global Autoimmune Disease Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Autoimmune Disease Treatment Players in Global Market
3.2 Top Global Autoimmune Disease Treatment Companies Ranked by Revenue
3.3 Global Autoimmune Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Autoimmune Disease Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Autoimmune Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autoimmune Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Autoimmune Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Autoimmune Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Autoimmune Disease Treatment Market Size Markets, 2021 & 2027
4.1.2 Immunosuppressant's
4.1.3 Anti-Inflammatory Drugs
4.1.4 Corticosteroids
4.1.5 Nonsteroidal Anti-inflammatory Drugs
4.1.6 Biologics
4.2 By Type - Global Autoimmune Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Autoimmune Disease Treatment Revenue, 2016-2021
4.2.2 By Type - Global Autoimmune Disease Treatment Revenue, 2022-2027
4.2.3 By Type - Global Autoimmune Disease Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Autoimmune Disease Treatment Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Drug Stores
5.1.5 Other
5.2 By Application - Global Autoimmune Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Autoimmune Disease Treatment Revenue, 2016-2021
5.2.2 By Application - Global Autoimmune Disease Treatment Revenue, 2022-2027
5.2.3 By Application - Global Autoimmune Disease Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Autoimmune Disease Treatment Market Size, 2021 & 2027
6.2 By Region - Global Autoimmune Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Autoimmune Disease Treatment Revenue, 2016-2021
6.2.2 By Region - Global Autoimmune Disease Treatment Revenue, 2022-2027
6.2.3 By Region - Global Autoimmune Disease Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Autoimmune Disease Treatment Revenue, 2016-2027
6.3.2 US Autoimmune Disease Treatment Market Size, 2016-2027
6.3.3 Canada Autoimmune Disease Treatment Market Size, 2016-2027
6.3.4 Mexico Autoimmune Disease Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Autoimmune Disease Treatment Revenue, 2016-2027
6.4.2 Germany Autoimmune Disease Treatment Market Size, 2016-2027
6.4.3 France Autoimmune Disease Treatment Market Size, 2016-2027
6.4.4 U.K. Autoimmune Disease Treatment Market Size, 2016-2027
6.4.5 Italy Autoimmune Disease Treatment Market Size, 2016-2027
6.4.6 Russia Autoimmune Disease Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Autoimmune Disease Treatment Market Size, 2016-2027
6.4.8 Benelux Autoimmune Disease Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Autoimmune Disease Treatment Revenue, 2016-2027
6.5.2 China Autoimmune Disease Treatment Market Size, 2016-2027
6.5.3 Japan Autoimmune Disease Treatment Market Size, 2016-2027
6.5.4 South Korea Autoimmune Disease Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Autoimmune Disease Treatment Market Size, 2016-2027
6.5.6 India Autoimmune Disease Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Autoimmune Disease Treatment Revenue, 2016-2027
6.6.2 Brazil Autoimmune Disease Treatment Market Size, 2016-2027
6.6.3 Argentina Autoimmune Disease Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Autoimmune Disease Treatment Revenue, 2016-2027
6.7.2 Turkey Autoimmune Disease Treatment Market Size, 2016-2027
6.7.3 Israel Autoimmune Disease Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Autoimmune Disease Treatment Market Size, 2016-2027
6.7.5 UAE Autoimmune Disease Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Autoimmune Disease Treatment Major Product Offerings
7.1.4 Abbott Laboratories Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.1.5 Abbott Laboratories Key News
7.2 Active Biotech
7.2.1 Active Biotech Corporate Summary
7.2.2 Active Biotech Business Overview
7.2.3 Active Biotech Autoimmune Disease Treatment Major Product Offerings
7.2.4 Active Biotech Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.2.5 Active Biotech Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Autoimmune Disease Treatment Major Product Offerings
7.3.4 Eli Lilly Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.3.5 Eli Lilly Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Autoimmune Disease Treatment Major Product Offerings
7.4.4 Bristol-Myers Squibb Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.4.5 Bristol-Myers Squibb Key News
7.5 AstraZeneca plc
7.5.1 AstraZeneca plc Corporate Summary
7.5.2 AstraZeneca plc Business Overview
7.5.3 AstraZeneca plc Autoimmune Disease Treatment Major Product Offerings
7.5.4 AstraZeneca plc Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.5.5 AstraZeneca plc Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Autoimmune Disease Treatment Major Product Offerings
7.6.4 Pfizer Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.6.5 Pfizer Key News
7.7 Biogen Idec
7.7.1 Biogen Idec Corporate Summary
7.7.2 Biogen Idec Business Overview
7.7.3 Biogen Idec Autoimmune Disease Treatment Major Product Offerings
7.4.4 Biogen Idec Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.7.5 Biogen Idec Key News
7.8 Lupin Limited
7.8.1 Lupin Limited Corporate Summary
7.8.2 Lupin Limited Business Overview
7.8.3 Lupin Limited Autoimmune Disease Treatment Major Product Offerings
7.8.4 Lupin Limited Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.8.5 Lupin Limited Key News
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Corporate Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Autoimmune Disease Treatment Major Product Offerings
7.9.4 GlaxoSmithKline Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.9.5 GlaxoSmithKline Key News
7.10 Amgen
7.10.1 Amgen Corporate Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Autoimmune Disease Treatment Major Product Offerings
7.10.4 Amgen Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.10.5 Amgen Key News
7.11 4SC AG
7.11.1 4SC AG Corporate Summary
7.11.2 4SC AG Business Overview
7.11.3 4SC AG Autoimmune Disease Treatment Major Product Offerings
7.11.4 4SC AG Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.11.5 4SC AG Key News
7.12 F. Hoffmann-La Roche Ltd.
7.12.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.12.2 F. Hoffmann-La Roche Ltd. Business Overview
7.12.3 F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Major Product Offerings
7.12.4 F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.12.5 F. Hoffmann-La Roche Ltd. Key News
7.13 AutoImmune Inc
7.13.1 AutoImmune Inc Corporate Summary
7.13.2 AutoImmune Inc Business Overview
7.13.3 AutoImmune Inc Autoimmune Disease Treatment Major Product Offerings
7.13.4 AutoImmune Inc Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.13.5 AutoImmune Inc Key News
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Corporate Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Autoimmune Disease Treatment Major Product Offerings
7.14.4 Johnson & Johnson Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.14.5 Johnson & Johnson Key News
7.15 Bayer
7.15.1 Bayer Corporate Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Autoimmune Disease Treatment Major Product Offerings
7.15.4 Bayer Autoimmune Disease Treatment Revenue in Global (2016-2021)
7.15.5 Bayer Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Autoimmune Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Autoimmune Disease Treatment Market Drivers in Global Market
Table 3. Autoimmune Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Autoimmune Disease Treatment in Global Market
Table 5. Top Autoimmune Disease Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Autoimmune Disease Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Autoimmune Disease Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Autoimmune Disease Treatment Product Type
Table 9. List of Global Tier 1 Autoimmune Disease Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autoimmune Disease Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Autoimmune Disease Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Autoimmune Disease Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Autoimmune Disease Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Autoimmune Disease Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Autoimmune Disease Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Autoimmune Disease Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Autoimmune Disease Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Autoimmune Disease Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Autoimmune Disease Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Autoimmune Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Autoimmune Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Autoimmune Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Autoimmune Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Autoimmune Disease Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Autoimmune Disease Treatment Product Offerings
Table 32. Abbott Laboratories Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Active Biotech Corporate Summary
Table 34. Active Biotech Autoimmune Disease Treatment Product Offerings
Table 35. Active Biotech Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Autoimmune Disease Treatment Product Offerings
Table 38. Eli Lilly Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Autoimmune Disease Treatment Product Offerings
Table 41. Bristol-Myers Squibb Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 42. AstraZeneca plc Corporate Summary
Table 43. AstraZeneca plc Autoimmune Disease Treatment Product Offerings
Table 44. AstraZeneca plc Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Autoimmune Disease Treatment Product Offerings
Table 47. Pfizer Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Biogen Idec Corporate Summary
Table 49. Biogen Idec Autoimmune Disease Treatment Product Offerings
Table 50. Biogen Idec Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Lupin Limited Corporate Summary
Table 52. Lupin Limited Autoimmune Disease Treatment Product Offerings
Table 53. Lupin Limited Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 54. GlaxoSmithKline Corporate Summary
Table 55. GlaxoSmithKline Autoimmune Disease Treatment Product Offerings
Table 56. GlaxoSmithKline Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 57. Amgen Corporate Summary
Table 58. Amgen Autoimmune Disease Treatment Product Offerings
Table 59. Amgen Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 60. 4SC AG Corporate Summary
Table 61. 4SC AG Autoimmune Disease Treatment Product Offerings
Table 62. 4SC AG Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 63. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 64. F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Product Offerings
Table 65. F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 66. AutoImmune Inc Corporate Summary
Table 67. AutoImmune Inc Autoimmune Disease Treatment Product Offerings
Table 68. AutoImmune Inc Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 69. Johnson & Johnson Corporate Summary
Table 70. Johnson & Johnson Autoimmune Disease Treatment Product Offerings
Table 71. Johnson & Johnson Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
Table 72. Bayer Corporate Summary
Table 73. Bayer Autoimmune Disease Treatment Product Offerings
Table 74. Bayer Autoimmune Disease Treatment Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Autoimmune Disease Treatment Segment by Type
Figure 2. Autoimmune Disease Treatment Segment by Application
Figure 3. Global Autoimmune Disease Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Autoimmune Disease Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Autoimmune Disease Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autoimmune Disease Treatment Revenue in 2020
Figure 8. By Type - Global Autoimmune Disease Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Autoimmune Disease Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Autoimmune Disease Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Autoimmune Disease Treatment Revenue Market Share, 2016-2027
Figure 12. US Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Autoimmune Disease Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Autoimmune Disease Treatment Revenue Market Share, 2016-2027
Figure 24. China Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Autoimmune Disease Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Autoimmune Disease Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Autoimmune Disease Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Abbott Laboratories Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Active Biotech Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Eli Lilly Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bristol-Myers Squibb Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. AstraZeneca plc Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Pfizer Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Biogen Idec Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Lupin Limited Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. GlaxoSmithKline Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Amgen Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. 4SC AG Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. AutoImmune Inc Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Johnson & Johnson Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Bayer Autoimmune Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Abbott Laboratories
Active Biotech
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
Pfizer
Biogen Idec
Lupin Limited
GlaxoSmithKline
Amgen
4SC AG
F. Hoffmann-La Roche Ltd.
AutoImmune Inc
Johnson & Johnson
Bayer